Completed OBSERVATIONAL NCT06020456

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A (GIDEHAC)

Study of Genetic Factors Influencing the Factor VIII Response to Desmopressin in Carriers of Hemophilia A: the GIDEHAC Study

Sponsor: Groupe Maladies hémorragiques de Bretagne

Conditions Carrier of Hemophilia A Desmopressin Factor VIII Deficiency

Interventions Desmopressin

Updated 4 times since 2023 Last updated: Aug 28, 2023 Started: Jan 1, 2022 Primary completion: Jan 1, 2023 Completion: Apr 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06020456, this observational or N/A phase trial focuses on Carrier of Hemophilia A and Desmopressin and remains completed. Sponsored by Groupe Maladies hémorragiques de Bretagne, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2023 — Jul 2024 [monthly]

Completed

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Groupe Maladies hémorragiques de Bretagne

Data source: Groupe Maladies hémorragiques de Bretagne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bordeaux, France , Brest, France , Bron, France , Dijon, France , Le Kremlin-Bicêtre, France , Lille, France , Marseille, France , Montpellier, France , Nancy, France , Nantes, France and 2 more locations